Immunomedics

Pharma CFO Charged With Insider Trading
Risk & Compliance

Pharma CFO Charged With Insider Trading

Usama Malik allegedly gave nonpublic information about an Immunomedics drug to his then-girlfriend while he was the firm's CFO.
By Matthew Heller | December 3, 2021
Read More
Gilead to Buy Cancer Drugmaker for $21 Billion
M&A

Gilead to Buy Cancer Drugmaker for $21 Billion

The acquisition of Immunomedics "represents significant progress in Gilead’s work to build a strong and diverse oncology portfolio."
By Matthew Heller | September 14, 2020
Read More